Abstract
Thrombolysis with intravenous alteplase has been proven an effective treatment for patients with acute ischemic stroke in randomized clinical trials. In daily practice, the effect of thrombolysis may be less, and complications may occur more often.
Original language | English |
---|---|
Pages (from-to) | 289-92 |
Number of pages | 4 |
Journal | International Journal of Stroke |
Volume | 7 |
Issue number | 4 |
DOIs | |
Publication status | Published - Jun 2012 |
Keywords
- Aged
- Aged, 80 and over
- Brain Ischemia
- Female
- Fibrinolytic Agents
- Humans
- Infusions, Intravenous
- Male
- Stroke
- Tissue Plasminogen Activator
- Treatment Outcome